JP2004522945A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004522945A5 JP2004522945A5 JP2002546211A JP2002546211A JP2004522945A5 JP 2004522945 A5 JP2004522945 A5 JP 2004522945A5 JP 2002546211 A JP2002546211 A JP 2002546211A JP 2002546211 A JP2002546211 A JP 2002546211A JP 2004522945 A5 JP2004522945 A5 JP 2004522945A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- staau
- candidate compound
- bacteriophage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/727,892 US20040091856A1 (en) | 1999-12-01 | 2000-12-01 | DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides |
| US88556101A | 2001-06-20 | 2001-06-20 | |
| PCT/CA2001/001754 WO2002044718A2 (en) | 2000-11-30 | 2001-11-30 | S.aureus protein staau r2, gene encoding it and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004522945A JP2004522945A (ja) | 2004-07-29 |
| JP2004522945A5 true JP2004522945A5 (https=) | 2005-07-07 |
Family
ID=27111604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002546211A Pending JP2004522945A (ja) | 2000-12-01 | 2001-11-30 | スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質staau_r2に関連する組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1340079A2 (https=) |
| JP (1) | JP2004522945A (https=) |
| AU (2) | AU2042202A (https=) |
| CA (1) | CA2428595A1 (https=) |
| WO (1) | WO2002044718A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116908265B (zh) * | 2023-09-11 | 2023-12-12 | 常州先趋医疗科技有限公司 | 检测核酸lamp扩增产物电化学生物传感器的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU774841B2 (en) * | 1998-12-03 | 2004-07-08 | Targanta Therapeutics Inc. | Development of novel anti-microbial agents based on bacteriophage genomics |
| EP1242611A4 (en) * | 1999-12-22 | 2004-08-11 | Phagetech Inc | COMPOSITIONS AND METHODS USING AN ESSENTIAL STAPHYLOCOCUS AUREUS GENE AND ITS ENCODED PROTEIN |
-
2001
- 2001-11-30 CA CA002428595A patent/CA2428595A1/en not_active Abandoned
- 2001-11-30 JP JP2002546211A patent/JP2004522945A/ja active Pending
- 2001-11-30 AU AU2042202A patent/AU2042202A/xx active Pending
- 2001-11-30 EP EP01998823A patent/EP1340079A2/en not_active Withdrawn
- 2001-11-30 AU AU2002220422A patent/AU2002220422B2/en not_active Ceased
- 2001-11-30 WO PCT/CA2001/001754 patent/WO2002044718A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240366694A1 (en) | Phage therapy of e coli infections | |
| JP6355792B2 (ja) | 抗菌性ファージ、ファージペプチド、及びそれらの使用方法 | |
| AU2007272272B2 (en) | Antimicrobial peptides | |
| JP2006519605A5 (https=) | ||
| JPH11335396A (ja) | 新規抗菌性ペプチド | |
| JP2012517225A5 (https=) | ||
| JPH08508248A (ja) | 殺菌性/透過性が向上したタンパク質の機能領域に由来する生物学的に活性なペプチドおよびその使用 | |
| CN105377250B (zh) | 用于对抗抗菌剂抗性细菌的组合物和方法 | |
| JP2011526920A5 (https=) | ||
| WO2016071503A1 (en) | Phage therapy | |
| EP3060226A1 (en) | Phage therapy of pseudomonas infections | |
| WO2010014830A4 (en) | Peptide therapeutics that bind vegf and methods of use thereof | |
| US6172185B1 (en) | Antimicrobial cationic peptide derivatives of bactenecin | |
| EP1294745A2 (en) | Antimicrobial peptides and methods of use thereof | |
| JP2004522945A5 (https=) | ||
| JP2008522632A5 (https=) | ||
| JP2004532612A5 (https=) | ||
| Dedent et al. | Staphylococcal sortases and surface proteins | |
| US20090162379A1 (en) | Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor | |
| JP2008514196A5 (https=) | ||
| US20210138025A1 (en) | Cationic peptides with immunomodulatory and/or anti-biofilm activities | |
| CA2262819A1 (en) | Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein | |
| CA2966944C (en) | Pseudomonas aeruginosa bacteriophage therapy | |
| WO2025094120A1 (en) | Cationic peptides with broad spectrum activity | |
| CA2953742A1 (en) | Use of metalloproteinase inhibitors against bacterial infections |